Freenome ( $FRNM ): Could the Stock Climb +25% Toward $20? (Check any stock’s price target on Tickeron.) Freenome, Inc. (FRNM) is a development-stage biotech focused on blood-based early cancer detection, and the question is whether its stock can reach a $20 price target from roughly $16. Reaching $20 would require the stock to climb about 25% and decisively clear its 52-week high of $17.50. $IQV $ILMN $GH $ADPT
published
Freenome ( $FRNM ): Could the Stock Climb +25% Toward $20? (Check any stock’s price target on Tickeron.) Freenome, Inc. (FRNM) is a development-stage biotech focused on blood-based early cancer detection, and the question is whether its stock can reach a $20 p
$FRNM$IQV$ILMN$GH$ADPT
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.